Professor Michele Barbour
M.Phys.(Oxon.), Ph.D.(Bristol)
Expertise
I am Associate Pro Vice-Chancellor Enterprise & Innovation within the UoB senior team, and also Professor of Biomaterials, leading a research group and overseeing biomaterials education at Bristol Dental School.
Current positions
Associate Pro Vice-Chancellor (Enterprise & Innovation)
Senior TeamProfessor of Biomaterials
Bristol Dental School
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
My research group has research interests in the development, characterisation and application of multifunctional clinical nanomaterials. Of particular interest are antimicrobial and antifungal technologies.
In the course of our research we developed and characterised a novel antmicrobial technology based on chlorhexidine, which can be used in a wide range of dental and medical materials and devices. This patented technology and the associated Intellectual Property is now owned and marketed by my spin-out company, Pertinax Pharma Ltd.
Projects and supervisions
Research projects
Saving neonates' lives by preventing umbilical cord infection: Cheap and effective spray delivery of sustained efficacy chlorhexidine
Principal Investigator
Managing organisational unit
Bristol Dental SchoolDates
01/10/2016 to 31/01/2017
8063 EPSRC EP/M027546/1
Principal Investigator
Description
BristolBridge: A sustained delivery chlorhexidine gel for prevention of umbilical cord infection in developing countriesManaging organisational unit
Bristol Dental SchoolDates
01/08/2016
Link account to CHEM RB1768 (EP/M027546/1) - BristolBridge: Sustained chlorhexidine delivery gels for care of the umbilical cord in developing countries
Principal Investigator
Managing organisational unit
Bristol Dental SchoolDates
01/11/2015 to 31/01/2016
EIDF: £9500: Commercial exploitation of chlorhexidine nanoparticles: formulation of a commercialization blueprint including assessment of opportunities, risks and regulatory hurdles
Principal Investigator
Description
£9500Managing organisational unit
Bristol Dental SchoolDates
24/11/2014 to 28/02/2015
Development and characterisation of a wound dressing incorporating novel antimicrobial nanoparticles to prevent infection at venous catheter entry sites
Principal Investigator
Description
EPSRC Impact Acceleration Account projectManaging organisational unit
Bristol Dental SchoolDates
01/03/2014 to 01/03/2015
Thesis supervisions
Enhancing the Strength of Conventional Glass Ionomer Cements Using Nanomaterials
Supervisors
Development of a Chlorhexidine-Hexametaphosphate Coating for Titanium to Combat Early Implant Failure
Supervisors
Creating hierachical particle assemblies using organo-clays
Supervisors
Antimicrobial bone cements without antibiotics
Supervisors
Publications
Recent publications
20/11/2021A novel chlorhexidine-hexametaphosphate coating for titanium with antibiofilm efficacy and stem cell cytocompatibility
Journal of Materials Science: Materials in Medicine
Alginate films augmented with chlorhexidine hexametaphosphate particles provide sustained antimicrobial properties for application in wound care
Journal of Materials Science: Materials in Medicine
Chlorhexidine hexametaphosphate as a coating for elastomeric ligatures with sustained antimicrobial properties
American Journal of Orthodontics and Dentofacial Orthopedics
Halloysite Nanotubes as Nanofillers to Reinforce Glass Ionomer Cements
Journal of Medical Materials and Technologies
A novel flow-system to establish experimental biofilms for modelling chronic wound infection and testing the efficacy of wound dressings
Microbiological Research